KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children



Status:Terminated
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:Any - 3
Updated:1/12/2019
Start Date:July 3, 2018
End Date:October 18, 2018

Use our guide to learn which trials are right for you!

Safety and Efficacy of KPI-121 1% Ophthalmic Suspension Versus Prednisolone Acetate Ophthalmic Suspension 1% for the Treatment of Inflammation Following Cataract Surgery in Children 0 to 3 Years of Age

This study is designed to assess how KPI-121 1% compares to prednisolone acetate in reducing
inflammation after cataract surgery in young children. Approximately half the participants
will receive KPI-121 1% eye drops and the other half will receive prednisolone acetate.


Inclusion Criteria:

- Be a candidate for routine, uncomplicated cataract surgery

Exclusion Criteria:

- Have a post-traumatic cataract.

- Have suspected permanent low vision or blindness in the fellow non-study eye.

- Have active uveitis in either eye.

- Have an ocular neoplasm in either eye.

- Have the presence of viral, bacterial, or fungal disease in either eye.

- Have glaucoma, ocular hypertension, steroid-induced IOP rise or elevated IOP
We found this trial at
4
sites
Palo Alto, California 94303
2099
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Detroit, Michigan 48201
?
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
128 West 12th Street
Erie, Pennsylvania 16501
213
mi
from 43215
Erie, PA
Click here to add this to my saved trials
1699 Research Forest Drive
The Woodlands, Texas 77381
973
mi
from 43215
The Woodlands, TX
Click here to add this to my saved trials